Sunzen Biotech Bhd (0148) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sunzen Biotech Bhd (0148) has a cash flow conversion efficiency ratio of 0.027x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (RM3.58 Million ≈ $897.56K USD) by net assets (RM134.42 Million ≈ $33.75 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 0148 company net worth for the company's overall valuation and market capitalisation.
Sunzen Biotech Bhd - Cash Flow Conversion Efficiency Trend (2016–2023)
This chart illustrates how Sunzen Biotech Bhd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Sunzen Biotech Bhd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sunzen Biotech Bhd ranked by their cash flow conversion efficiency. Explore 0148 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hastings Technology Metals Ltd
AU:HAS
|
-0.035x |
|
AViTA Corporation
TWO:4735
|
0.037x |
|
Metal Sky Star Acquisition Corporation Ordinary shares
NASDAQ:MSSA
|
-0.003x |
|
Xander International
TWO:6118
|
-0.158x |
|
S P V I Public Company Limited
BK:SPVI
|
0.102x |
|
Batm Advanced Communications Ltd
TA:BVC
|
0.015x |
|
YNH Property Bhd
KLSE:3158
|
0.056x |
|
Sportsmans
NASDAQ:SPWH
|
0.078x |
Annual Cash Flow Conversion Efficiency for Sunzen Biotech Bhd (2016–2023)
The table below shows the annual cash flow conversion efficiency of Sunzen Biotech Bhd from 2016 to 2023. View 0148 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | RM149.84 Million ≈ $37.62 Million |
RM819.39K ≈ $205.72K |
0.005x | +102.08% |
| 2022-12-31 | RM121.88 Million ≈ $30.60 Million |
RM-32.06 Million ≈ $-8.05 Million |
-0.263x | -89.88% |
| 2021-12-31 | RM118.10 Million ≈ $29.65 Million |
RM-16.36 Million ≈ $-4.11 Million |
-0.139x | -268.20% |
| 2020-12-31 | RM87.47 Million ≈ $21.96 Million |
RM7.20 Million ≈ $1.81 Million |
0.082x | +168.12% |
| 2019-12-31 | RM91.37 Million ≈ $22.94 Million |
RM-11.05 Million ≈ $-2.77 Million |
-0.121x | -217.88% |
| 2018-12-31 | RM106.94 Million ≈ $26.85 Million |
RM-4.07 Million ≈ $-1.02 Million |
-0.038x | -194.09% |
| 2017-12-31 | RM99.45 Million ≈ $24.97 Million |
RM4.02 Million ≈ $1.01 Million |
0.040x | +1434.55% |
| 2016-12-31 | RM97.23 Million ≈ $24.41 Million |
RM256.13K ≈ $64.31K |
0.003x | -- |
About Sunzen Biotech Bhd
Sunzen Group Berhad, an investment holding company, engages in the biotechnology research and development, manufacturing, and marketing of animal feed supplement products in Malaysia, China, Singapore, and internationally. It operates through Human Health, Medical Devices and Services, and Loan Financing segments. The company provides veterinary, pharmaceutical, chemical products, animal health, … Read more